Utility of Bowel Ultrasound in Diagnosing Necrotizing Eneterocolitis in Congenital Heart Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Enterocolitis, Necrotizing, Congenital Heart Disease

In brief

To evaluate the feasibility of performing a randomized pilot control trial of two diagnostic screening strategies for necrotizing enterocolitis in patients with congenital heart disease. Measures to evaluate will be the ability to obtain consent from patients, percentage of eligible patients that are able to be recruited, coordination of providers, estimation of degree of crossover and ability to perform the screening exams per protocol.

Key facts

Study ID

NCT03142685

Run by

Children's Mercy Hospital Kansas City

People needed

0

Starts

2017-01-01

Expected to finish

2018-06-30

Last updated by the study team

2018-07-18

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients age 0-6 months with CHD
• Completed one or more cardiac surgeries for CHD
• Clinicians are suspicious for NEC and order an abdominal radiograph for screening.

You may not qualify if…

• Patients with isolated PDA or PFO congenital cardiac abnormalities
• Unable to ultrasound the bowel (eg. gut in silo)
• Prior heart transplant

Where it is running

• Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.